BOOST

HMB supplementation to improve functional status in people with advanced liver cirrhosis
Human liver, anatomy illustration
An ‘Expression of Interest' form will be coming soon; we expect our first sites to open in spring 2025
BOOST is a National Institute for Health Research, Research for Patient Benefit funded study for people with advanced liver cirrhosis, sponsored by University Hospital Plymouth NHS Trust and managed by the University of Plymouth's Peninsula Clinical Trials Unit .
This project aims to address the lack of treatment options for people with liver cirrhosis by testing whether the dietary supplement beta-hydroxy beta-methylbutyrate (HMB) improves their physical function and quality of life.